Integra Lifesciences Holdings (IART) Long-Term Deferred Tax (2016 - 2026)
Integra Lifesciences Holdings' Long-Term Deferred Tax history spans 17 years, with the latest figure at $69.9 million for Q4 2025.
- On a quarterly basis, Long-Term Deferred Tax rose 100.02% to $69.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $69.9 million, a 100.02% increase, with the full-year FY2025 number at $69.9 million, up 100.02% from a year prior.
- Long-Term Deferred Tax hit $69.9 million in Q4 2025 for Integra Lifesciences Holdings, down from $109.7 million in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for IART hit a ceiling of $109.7 million in Q3 2025 and a floor of $34.2 million in Q1 2024.
- Historically, Long-Term Deferred Tax has averaged $59.5 million across 5 years, with a median of $53.2 million in 2022.
- Biggest five-year swings in Long-Term Deferred Tax: soared 3102.83% in 2021 and later crashed 43.61% in 2022.
- Tracing IART's Long-Term Deferred Tax over 5 years: stood at $57.0 million in 2021, then decreased by 19.24% to $46.0 million in 2022, then increased by 0.19% to $46.1 million in 2023, then fell by 24.21% to $34.9 million in 2024, then skyrocketed by 100.02% to $69.9 million in 2025.
- Business Quant data shows Long-Term Deferred Tax for IART at $69.9 million in Q4 2025, $109.7 million in Q3 2025, and $102.9 million in Q2 2025.